RGC
Regencell Bioscience Holdings Ltd
NASDAQ: RGC · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$28.95
-0.34% today
Updated 2026-04-29
Market cap
$14.32B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.01
Dividend yield
—
52W range
$2 – $84
Volume
0.1M
Regencell Bioscience Holdings Ltd (RGC) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $386.00M | $304.00M | $800.00M | $270.00M | $410.80M | $259.40M | $353.10M | $346.60M | $346.90M | $349.10M | $434.40M | $410.50M | $409.90M | $-390990.00 | $-726573.00 | $-767311.00 | $-5.27M | $-4.96M | $-4.00M | $-3.11M |
| Capital expenditures | $0.00 | $0.00 | $0.00 | $0.00 | $108.80M | $98.40M | $87.20M | $89.20M | $112.10M | $156.80M | $185.70M | $214.90M | $250.40M | $117837.00 | $117837.00 | $780876.00 | $780876.00 | $27392.00 | $5376.00 | $152693.00 |
| Depreciation | $199.00M | $197.00M | $183.00M | $202.00M | $201.90M | $226.20M | $201.70M | $186.20M | $204.50M | $212.00M | $216.80M | $230.70M | $254.80M | $9516.00 | $9516.00 | $26456.00 | $604397.00 | $769687.00 | $745588.00 | $392743.00 |
| Stock-based comp | $5.00M | $8.00M | $5.00M | $5.00M | $5.90M | $8.40M | $7.90M | $10.30M | $9.30M | $9.40M | $8.30M | $8.80M | $9.20M | — | $0.00 | $0.00 | $2.76M | $930000.00 | $449311.00 | — |
| Free cash flow | $386.00M | $304.00M | $800.00M | $270.00M | $302.00M | $161.00M | $265.90M | $257.40M | $234.80M | $192.30M | $248.70M | $195.60M | $159.50M | $-508827.00 | $-844410.00 | $-1.55M | $-6.05M | $-4.99M | $-4.01M | $-3.27M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | $-117837.00 | $-117837.00 | $-10.78M | $-10.78M | $58978.00 | $5.24M | $2.69M |
| Financing cash flow | $-191.00M | $-186.00M | $-480.00M | — | $-142.40M | $-299.50M | $-204.30M | $-306.70M | $83.20M | $-332.40M | $-178.60M | $-160.00M | $-17.00M | $480994.00 | $988082.00 | $439745.00 | $22.41M | $134913.00 | $102282.00 | — |
| Dividends paid | $175.00M | $179.00M | $485.00M | — | $110.80M | $327.10M | $129.80M | $287.30M | $132.20M | $294.80M | $139.10M | $138.90M | $138.90M | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |